Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor - PubMed (original) (raw)
. 1987 Feb 1;138(3):815-24.
- PMID: 2433330
Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor
R Nagasawa et al. J Immunol. 1987.
Abstract
Hybridomas were prepared from the spleen of a BALB/c mouse immunized with EL-4 T lymphoma cells. One, designated A1, was found to secrete a monoclonal antibody that reacted with two T lymphoma cells of C57BL origin, EL-4 and C6VLB, but not with normal C57BL/6 splenocytes or thymocytes, C57BL/6 T cell clones, or other T or B lymphomas by complement-mediated cytotoxicity or indirect immunofluorescent staining. Monoclonal antibody (MAb) A1 precipitated a protein that migrated at 85 kD under nonreducing and 43 kD under reducing conditions. The fact that the antigen defined by MAb A1 was a disulfide-linked dimer, together with the essentially clone-specific distribution of the reactive epitope, raised the possibility that the antibody defined an epitope of the antigen receptor. However, several additional observations revealed that the antibody defined a distinct and novel T cell surface structure. MAb 124-40, previously shown to react with the antigen receptor of C6VLB cells, reacted with variants of C6VLB that failed to express the A1 epitope. Sequential immunoprecipitation indicated that MAb A1 and MAb 124-40 reacted with distinct molecular species on C6VLB cells. Endoglycosidase digestion showed that the structure reactive with MAb A1 was not derived from that reactive with MAb 124-40 by addition of N-linked oligosaccharide residues. Two-dimensional gel electrophoretic analysis of precipitates obtained from radioiodinated C6VLB cells with MAb 124-40 resolved the alpha and beta subunits of the antigen receptor. Similar analysis of precipitates obtained with MAb A1 revealed only a single basic chain under reducing conditions, although anomalous mobility suggestive of a second, more acidic chain was observed under nonreducing conditions. Two-dimensional maps of tyrosine-containing chymotryptic peptides of the proteins isolated with MAb A1 and MAb 124-40 were completely different, suggesting that the molecules shared no peptides and were distinct in primary structure. Finally, cross-linking studies performed with a cleavable reagent indicated that the A1 molecule, unlike the antigen receptor defined with MAb 124-40, was not associated with additional, T3-like structures on the surface of C6VLB cells. Although the MAb A1 was unreactive with normal cells in cytotoxicity or staining assays, a molecule of the appropriate size was immunoprecipitated in small amounts from lysates of radioiodinated normal spleen and thymus cells. These data indicate that MAb A1 defines a novel disulfide-linked T cell surface molecule distinct from the antigen receptor.
Similar articles
- Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.
Allison JP, McIntyre BW, Bloch D. Allison JP, et al. J Immunol. 1982 Nov;129(5):2293-300. J Immunol. 1982. PMID: 6181166 - The human T-cell receptor. Structure and function.
Acuto O, Reinherz EL. Acuto O, et al. N Engl J Med. 1985 Apr 25;312(17):1100-11. doi: 10.1056/NEJM198504253121706. N Engl J Med. 1985. PMID: 3885036 Review. No abstract available. - [Monoclonal hybrid antibodies. New perspectives for basic research and tumor therapy].
Zepp F, Staerz UD. Zepp F, et al. Monatsschr Kinderheilkd. 1992 Oct;140(10):745-52. Monatsschr Kinderheilkd. 1992. PMID: 1435794 Review. German.
Cited by
- Kinetics of gene expression in murine cutaneous graft-versus-host disease.
Sugerman PB, Faber SB, Willis LM, Petrovic A, Murphy GF, Pappo J, Silberstein D, van den Brink MR. Sugerman PB, et al. Am J Pathol. 2004 Jun;164(6):2189-202. doi: 10.1016/S0002-9440(10)63776-5. Am J Pathol. 2004. PMID: 15161652 Free PMC article. - Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules.
Tanamachi DM, Hanke T, Takizawa H, Jamieson AM, Raulet DR. Tanamachi DM, et al. J Exp Med. 2001 Feb 5;193(3):307-15. doi: 10.1084/jem.193.3.307. J Exp Med. 2001. PMID: 11157051 Free PMC article. - Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.
Chalifour A, Roger J, Lemieux S, Duplay P. Chalifour A, et al. Immunology. 2003 May;109(1):58-67. doi: 10.1046/j.1365-2567.2003.01618.x. Immunology. 2003. PMID: 12709018 Free PMC article. - Evidence for additional subunits associated to the mouse interleukin 2 receptor p55/p75 complex.
Saragovi H, Malek TR. Saragovi H, et al. Proc Natl Acad Sci U S A. 1990 Jan;87(1):11-5. doi: 10.1073/pnas.87.1.11. Proc Natl Acad Sci U S A. 1990. PMID: 2296573 Free PMC article. - A natural killer cell receptor specific for a major histocompatibility complex class I molecule.
Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM. Daniels BF, et al. J Exp Med. 1994 Aug 1;180(2):687-92. doi: 10.1084/jem.180.2.687. J Exp Med. 1994. PMID: 8046342 Free PMC article.